Enhanced peroxynitrite decomposition protects against experimental obliterative bronchiolitis

Babu V. Naidu, Alexander S. Farivar, Steven M. Woolley, Charles Fraga, Andrew L. Salzman, Csaba Szabo, John T. Groves, Michael S. Mulligan

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Obliterative bronchiolitis (OB) affects over half of all survivors following lung or heart-lung transplantation. Respiratory epithelial cell injury, peribronchial inflammation, and proliferation of fibrovascular tissue causing airway occlusion characterize the lesion. While peroxynitrite is known to participate in other models of acute lung injury, its role in the evolution of OB is unclear. Using a rat model of experimental OB, tracheas from Brown-Norway or Lewis rats were transplanted into Lewis recipients. Treated animals received FP-15, a peroxynitrite decomposition catalyst, at 1 mg/kg/day intraperitoneal for 14 days. Luminal obstruction, epithelial loss, and inflammatory infiltrate were examined, as was nitrotyrosine staining by immunohistochemistry in explanted tracheas. By postoperative day 14, control allografts demonstrated marked peribronchial inflammation, near complete loss of respiratory epithelium and extensive intraluminal proliferation of fibrovascular connective tissue, with a mean 83% reduction in airway cross-sectional area. Allograft recipients treated with FP-15 showed reduced nitrotyrosine formation, preservation of respiratory epithelium, limited peribronchial inflammation, and only 14% (P < .001) reduction in airway cross-sectional area. Peroxynitrite therefore appears to play a role in the development of obliterative bronchiolitis in rats. The peroxynitrite decomposition catalyst, FP-15, is protective when administered daily and warrants investigation into its potential clinical utility.

Original languageEnglish (US)
Pages (from-to)12-17
Number of pages6
JournalExperimental and Molecular Pathology
Volume75
Issue number1
DOIs
StatePublished - Aug 2003
Externally publishedYes

Fingerprint

Bronchiolitis
Peroxynitrous Acid
Decomposition
Rats
Respiratory Mucosa
Trachea
Inflammation
Allografts
Tissue
Heart-Lung Transplantation
Catalysts
Acute Lung Injury
Norway
Connective Tissue
Animals
Theoretical Models
Epithelial Cells
Immunohistochemistry
Staining and Labeling
Lung

Keywords

  • FP-15
  • Lung transplantation
  • Nitric oxide
  • Nitrotyrosine
  • Obliterative bronchiolitis
  • Peroxynitrite

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Molecular Biology
  • Pathology and Forensic Medicine

Cite this

Enhanced peroxynitrite decomposition protects against experimental obliterative bronchiolitis. / Naidu, Babu V.; Farivar, Alexander S.; Woolley, Steven M.; Fraga, Charles; Salzman, Andrew L.; Szabo, Csaba; Groves, John T.; Mulligan, Michael S.

In: Experimental and Molecular Pathology, Vol. 75, No. 1, 08.2003, p. 12-17.

Research output: Contribution to journalArticle

Naidu, BV, Farivar, AS, Woolley, SM, Fraga, C, Salzman, AL, Szabo, C, Groves, JT & Mulligan, MS 2003, 'Enhanced peroxynitrite decomposition protects against experimental obliterative bronchiolitis', Experimental and Molecular Pathology, vol. 75, no. 1, pp. 12-17. https://doi.org/10.1016/S0014-4800(03)00015-7
Naidu, Babu V. ; Farivar, Alexander S. ; Woolley, Steven M. ; Fraga, Charles ; Salzman, Andrew L. ; Szabo, Csaba ; Groves, John T. ; Mulligan, Michael S. / Enhanced peroxynitrite decomposition protects against experimental obliterative bronchiolitis. In: Experimental and Molecular Pathology. 2003 ; Vol. 75, No. 1. pp. 12-17.
@article{a8c6b2afc2f046fb8194882934bdc94f,
title = "Enhanced peroxynitrite decomposition protects against experimental obliterative bronchiolitis",
abstract = "Obliterative bronchiolitis (OB) affects over half of all survivors following lung or heart-lung transplantation. Respiratory epithelial cell injury, peribronchial inflammation, and proliferation of fibrovascular tissue causing airway occlusion characterize the lesion. While peroxynitrite is known to participate in other models of acute lung injury, its role in the evolution of OB is unclear. Using a rat model of experimental OB, tracheas from Brown-Norway or Lewis rats were transplanted into Lewis recipients. Treated animals received FP-15, a peroxynitrite decomposition catalyst, at 1 mg/kg/day intraperitoneal for 14 days. Luminal obstruction, epithelial loss, and inflammatory infiltrate were examined, as was nitrotyrosine staining by immunohistochemistry in explanted tracheas. By postoperative day 14, control allografts demonstrated marked peribronchial inflammation, near complete loss of respiratory epithelium and extensive intraluminal proliferation of fibrovascular connective tissue, with a mean 83{\%} reduction in airway cross-sectional area. Allograft recipients treated with FP-15 showed reduced nitrotyrosine formation, preservation of respiratory epithelium, limited peribronchial inflammation, and only 14{\%} (P < .001) reduction in airway cross-sectional area. Peroxynitrite therefore appears to play a role in the development of obliterative bronchiolitis in rats. The peroxynitrite decomposition catalyst, FP-15, is protective when administered daily and warrants investigation into its potential clinical utility.",
keywords = "FP-15, Lung transplantation, Nitric oxide, Nitrotyrosine, Obliterative bronchiolitis, Peroxynitrite",
author = "Naidu, {Babu V.} and Farivar, {Alexander S.} and Woolley, {Steven M.} and Charles Fraga and Salzman, {Andrew L.} and Csaba Szabo and Groves, {John T.} and Mulligan, {Michael S.}",
year = "2003",
month = "8",
doi = "10.1016/S0014-4800(03)00015-7",
language = "English (US)",
volume = "75",
pages = "12--17",
journal = "Experimental and Molecular Pathology",
issn = "0014-4800",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Enhanced peroxynitrite decomposition protects against experimental obliterative bronchiolitis

AU - Naidu, Babu V.

AU - Farivar, Alexander S.

AU - Woolley, Steven M.

AU - Fraga, Charles

AU - Salzman, Andrew L.

AU - Szabo, Csaba

AU - Groves, John T.

AU - Mulligan, Michael S.

PY - 2003/8

Y1 - 2003/8

N2 - Obliterative bronchiolitis (OB) affects over half of all survivors following lung or heart-lung transplantation. Respiratory epithelial cell injury, peribronchial inflammation, and proliferation of fibrovascular tissue causing airway occlusion characterize the lesion. While peroxynitrite is known to participate in other models of acute lung injury, its role in the evolution of OB is unclear. Using a rat model of experimental OB, tracheas from Brown-Norway or Lewis rats were transplanted into Lewis recipients. Treated animals received FP-15, a peroxynitrite decomposition catalyst, at 1 mg/kg/day intraperitoneal for 14 days. Luminal obstruction, epithelial loss, and inflammatory infiltrate were examined, as was nitrotyrosine staining by immunohistochemistry in explanted tracheas. By postoperative day 14, control allografts demonstrated marked peribronchial inflammation, near complete loss of respiratory epithelium and extensive intraluminal proliferation of fibrovascular connective tissue, with a mean 83% reduction in airway cross-sectional area. Allograft recipients treated with FP-15 showed reduced nitrotyrosine formation, preservation of respiratory epithelium, limited peribronchial inflammation, and only 14% (P < .001) reduction in airway cross-sectional area. Peroxynitrite therefore appears to play a role in the development of obliterative bronchiolitis in rats. The peroxynitrite decomposition catalyst, FP-15, is protective when administered daily and warrants investigation into its potential clinical utility.

AB - Obliterative bronchiolitis (OB) affects over half of all survivors following lung or heart-lung transplantation. Respiratory epithelial cell injury, peribronchial inflammation, and proliferation of fibrovascular tissue causing airway occlusion characterize the lesion. While peroxynitrite is known to participate in other models of acute lung injury, its role in the evolution of OB is unclear. Using a rat model of experimental OB, tracheas from Brown-Norway or Lewis rats were transplanted into Lewis recipients. Treated animals received FP-15, a peroxynitrite decomposition catalyst, at 1 mg/kg/day intraperitoneal for 14 days. Luminal obstruction, epithelial loss, and inflammatory infiltrate were examined, as was nitrotyrosine staining by immunohistochemistry in explanted tracheas. By postoperative day 14, control allografts demonstrated marked peribronchial inflammation, near complete loss of respiratory epithelium and extensive intraluminal proliferation of fibrovascular connective tissue, with a mean 83% reduction in airway cross-sectional area. Allograft recipients treated with FP-15 showed reduced nitrotyrosine formation, preservation of respiratory epithelium, limited peribronchial inflammation, and only 14% (P < .001) reduction in airway cross-sectional area. Peroxynitrite therefore appears to play a role in the development of obliterative bronchiolitis in rats. The peroxynitrite decomposition catalyst, FP-15, is protective when administered daily and warrants investigation into its potential clinical utility.

KW - FP-15

KW - Lung transplantation

KW - Nitric oxide

KW - Nitrotyrosine

KW - Obliterative bronchiolitis

KW - Peroxynitrite

UR - http://www.scopus.com/inward/record.url?scp=0038693336&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038693336&partnerID=8YFLogxK

U2 - 10.1016/S0014-4800(03)00015-7

DO - 10.1016/S0014-4800(03)00015-7

M3 - Article

C2 - 12834621

AN - SCOPUS:0038693336

VL - 75

SP - 12

EP - 17

JO - Experimental and Molecular Pathology

JF - Experimental and Molecular Pathology

SN - 0014-4800

IS - 1

ER -